The kaempferol market size has grown strongly in recent years. It will grow from $4.14 billion in 2024 to $4.35 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to plant-based nutrition research, biomedical and pharmacological studies, increased focus on antioxidants, biotechnological advancements, and botanical and phytochemical studies.
The kaempferol market size is expected to see steady growth in the next few years. It will grow to $5.24 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to health and wellness trends, increased focus on antimicrobial properties, genetic modification for enhanced production, healthcare shift towards preventive measures, and rise in personalized medicine. Major trends in the forecast period include kaempferol for cardiovascular health, kaempferol in sports nutrition, biofortification of crops for higher kaempferol content, increased research in neuroprotective effect, and kaempferol-fortified functional beverages.
The kaempferol market is anticipated to experience growth, propelled by the increasing prevalence of cancer. Cancer, a group of diseases characterized by the uncontrolled growth of abnormal cells that can invade surrounding tissues and potentially spread to other parts of the body, has led to a rising demand for kaempferol. Kaempferol, a phytoestrogen found in plants, exhibits anti-cancer properties by inducing apoptosis, arresting the cell cycle, and inhibiting processes such as blood vessel development, migration, and invasion of cancer cells. As reported in April 2022 by the American Cancer Society, there were 1.92 million new cancer cases in the U.S., showing an increase from 1.89 million cases in 2021. Consequently, the growing prevalence of cancer is a significant factor driving the growth of the kaempferol market.
The expansion of the food and beverage industry is anticipated to fuel the growth of the kaempferol market. The food and beverage industry, encompassing the production, processing, distribution, and sale of food and drink products, plays a pivotal role in the utilization of kaempferol. This natural bioactive compound is sought after for its antioxidant properties, prompting its incorporation into various products within the industry. Kaempferol is commonly used in functional foods, beverages, and dietary supplements to enhance nutritional profiles and meet consumer preferences for health-promoting ingredients. In 2023, the Food & Drink Federation reported a 31% increase in food and drink exports in 2022 compared to the previous year. Furthermore, the industry contributed significantly to the economy, with a turnover of $3.52 billion (£10.3 billion) in 2022, accounting for 33% of total Scottish manufacturing. The expanding footprint of the food and beverage industry is a major driver for the kaempferol market, as its applications continue to diversify within the sector.
The growing expansion of the cosmetics industry is expected to drive the growth of the kaempferol market in the future. The cosmetics industry encompasses the production, distribution, and sale of products aimed at personal care and beautification. Kaempferol is used in cosmetics due to its antioxidant properties and potential skin health benefits. Its anti-inflammatory and anti-aging qualities make it a desirable ingredient, commonly added to skincare products to enhance skin wellness and offer protection against environmental stressors. For example, in July 2022, the Canadian cosmetics industry generated around $1.24 billion in 2021, with industry revenue projected to rise by 1.45% annually, reaching $1.8 billion by 2024. Consequently, the expanding cosmetics industry is fueling the growth of the kaempferol market.
Product innovations are emerging as a prominent trend in the kaempferol industry, with major companies actively developing innovative products to maintain their market positions. Conagen, a leading biotechnology company based in the United States, exemplifies this trend with its January 2022 announcement. The company successfully developed antioxidant kaempferol through state-of-the-art, proprietary precision fermentation. Precision fermentation is highlighted for its effectiveness and environmental friendliness compared to alternative methods such as chemical synthesis or botanical sourcing for flavonoids such as kaempferol. Conagen's innovative approach enables brands in the nutrition, cosmetics, and personal care sectors to adopt a more natural stance by incorporating their kaempferol in formulations. This emphasis on innovation underscores the dynamic landscape of the kaempferol market, with companies actively pursuing advancements to meet evolving industry demands.
In December 2023, Danaher Corporation, a US-based manufacturer of medical products, acquired Abcam plc for $5.7 billion. This acquisition aims to bolster Danaher Corporation's position in the life sciences sector by incorporating Abcam's expertise in supplying high-quality biological reagents and tools, thereby enhancing its portfolio of innovative medical and research products. Abcam plc, a UK-based company, specializes in the production of biopharmaceuticals, including kaempferol.
Major companies operating in the kaempferol market include Fujifilm Wako Pure Chemical Corporation, Merk Millipore, LGC Group, Abcam plc, ChromaDex Corporation, Cayman Chemical Company, BioVision Inc., Clearsynth Labs Ltd., Enzo Life Sciences Inc., Santa Cruz Biotechnology Inc., AppliChem GmbH, Conagen Inc., MedChemExpress LLC, BioBioPha Co. Ltd., FoodChem International Corporation, Oakwood Products Inc., Spectrum Chemical Mfg. Corp., Aktin Chemicals Inc., BOC Sciences, AK Scientific Inc., Chemfaces Biochemical Co. Ltd, INDOFINE Chemical Company Inc., Risun Bio-Tech Inc., Shaanxi NHK Technology, TCI Chemicals (India) Pvt. Ltd.
North America was the largest region in the kaempferol market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kaempferol market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the kaempferol market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
Kaempferol is a yellow, crystalline flavonol compound found in plants, either in its free form or in conjunction with glycosidic compounds. It exhibits properties that aid in treating hormone-affected malignancies such as leukemia, ovarian, breast, cervical, hepatocellular, and ovarian cancers.
The kaempferol market is segmented based on its sources, including tea, fruits, vegetables, and medicinal plants. Within this segmentation, vegetables encompass a variety of edible plant parts - fruits, seeds, roots, tubers, bulbs, stems, leaves, or flowers - used for kaempferol extraction. This compound shows potential as a chemopreventive agent against cancer. Purity levels for kaempferol range from 10%, 20%, 50%, 95%, to 98%. Its applications span across diverse industries such as food and beverages, cosmetics, pharmaceuticals, dietary supplements, and more.
The kaempferol market research report is one of a series of new reports that provides kaempferol market statistics, including kaempferol industry global market size, regional shares, competitors with a kaempferol market share, detailed kaempferol market segments, market trends, and opportunities, and any further data you may need to thrive in the kaempferol industry. This kaempferol market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The kaempferol market consists of sales of luteolin, apigenin, flavanol, polyphenol, and glycoside. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The kaempferol market size is expected to see steady growth in the next few years. It will grow to $5.24 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to health and wellness trends, increased focus on antimicrobial properties, genetic modification for enhanced production, healthcare shift towards preventive measures, and rise in personalized medicine. Major trends in the forecast period include kaempferol for cardiovascular health, kaempferol in sports nutrition, biofortification of crops for higher kaempferol content, increased research in neuroprotective effect, and kaempferol-fortified functional beverages.
The kaempferol market is anticipated to experience growth, propelled by the increasing prevalence of cancer. Cancer, a group of diseases characterized by the uncontrolled growth of abnormal cells that can invade surrounding tissues and potentially spread to other parts of the body, has led to a rising demand for kaempferol. Kaempferol, a phytoestrogen found in plants, exhibits anti-cancer properties by inducing apoptosis, arresting the cell cycle, and inhibiting processes such as blood vessel development, migration, and invasion of cancer cells. As reported in April 2022 by the American Cancer Society, there were 1.92 million new cancer cases in the U.S., showing an increase from 1.89 million cases in 2021. Consequently, the growing prevalence of cancer is a significant factor driving the growth of the kaempferol market.
The expansion of the food and beverage industry is anticipated to fuel the growth of the kaempferol market. The food and beverage industry, encompassing the production, processing, distribution, and sale of food and drink products, plays a pivotal role in the utilization of kaempferol. This natural bioactive compound is sought after for its antioxidant properties, prompting its incorporation into various products within the industry. Kaempferol is commonly used in functional foods, beverages, and dietary supplements to enhance nutritional profiles and meet consumer preferences for health-promoting ingredients. In 2023, the Food & Drink Federation reported a 31% increase in food and drink exports in 2022 compared to the previous year. Furthermore, the industry contributed significantly to the economy, with a turnover of $3.52 billion (£10.3 billion) in 2022, accounting for 33% of total Scottish manufacturing. The expanding footprint of the food and beverage industry is a major driver for the kaempferol market, as its applications continue to diversify within the sector.
The growing expansion of the cosmetics industry is expected to drive the growth of the kaempferol market in the future. The cosmetics industry encompasses the production, distribution, and sale of products aimed at personal care and beautification. Kaempferol is used in cosmetics due to its antioxidant properties and potential skin health benefits. Its anti-inflammatory and anti-aging qualities make it a desirable ingredient, commonly added to skincare products to enhance skin wellness and offer protection against environmental stressors. For example, in July 2022, the Canadian cosmetics industry generated around $1.24 billion in 2021, with industry revenue projected to rise by 1.45% annually, reaching $1.8 billion by 2024. Consequently, the expanding cosmetics industry is fueling the growth of the kaempferol market.
Product innovations are emerging as a prominent trend in the kaempferol industry, with major companies actively developing innovative products to maintain their market positions. Conagen, a leading biotechnology company based in the United States, exemplifies this trend with its January 2022 announcement. The company successfully developed antioxidant kaempferol through state-of-the-art, proprietary precision fermentation. Precision fermentation is highlighted for its effectiveness and environmental friendliness compared to alternative methods such as chemical synthesis or botanical sourcing for flavonoids such as kaempferol. Conagen's innovative approach enables brands in the nutrition, cosmetics, and personal care sectors to adopt a more natural stance by incorporating their kaempferol in formulations. This emphasis on innovation underscores the dynamic landscape of the kaempferol market, with companies actively pursuing advancements to meet evolving industry demands.
In December 2023, Danaher Corporation, a US-based manufacturer of medical products, acquired Abcam plc for $5.7 billion. This acquisition aims to bolster Danaher Corporation's position in the life sciences sector by incorporating Abcam's expertise in supplying high-quality biological reagents and tools, thereby enhancing its portfolio of innovative medical and research products. Abcam plc, a UK-based company, specializes in the production of biopharmaceuticals, including kaempferol.
Major companies operating in the kaempferol market include Fujifilm Wako Pure Chemical Corporation, Merk Millipore, LGC Group, Abcam plc, ChromaDex Corporation, Cayman Chemical Company, BioVision Inc., Clearsynth Labs Ltd., Enzo Life Sciences Inc., Santa Cruz Biotechnology Inc., AppliChem GmbH, Conagen Inc., MedChemExpress LLC, BioBioPha Co. Ltd., FoodChem International Corporation, Oakwood Products Inc., Spectrum Chemical Mfg. Corp., Aktin Chemicals Inc., BOC Sciences, AK Scientific Inc., Chemfaces Biochemical Co. Ltd, INDOFINE Chemical Company Inc., Risun Bio-Tech Inc., Shaanxi NHK Technology, TCI Chemicals (India) Pvt. Ltd.
North America was the largest region in the kaempferol market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kaempferol market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the kaempferol market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
Kaempferol is a yellow, crystalline flavonol compound found in plants, either in its free form or in conjunction with glycosidic compounds. It exhibits properties that aid in treating hormone-affected malignancies such as leukemia, ovarian, breast, cervical, hepatocellular, and ovarian cancers.
The kaempferol market is segmented based on its sources, including tea, fruits, vegetables, and medicinal plants. Within this segmentation, vegetables encompass a variety of edible plant parts - fruits, seeds, roots, tubers, bulbs, stems, leaves, or flowers - used for kaempferol extraction. This compound shows potential as a chemopreventive agent against cancer. Purity levels for kaempferol range from 10%, 20%, 50%, 95%, to 98%. Its applications span across diverse industries such as food and beverages, cosmetics, pharmaceuticals, dietary supplements, and more.
The kaempferol market research report is one of a series of new reports that provides kaempferol market statistics, including kaempferol industry global market size, regional shares, competitors with a kaempferol market share, detailed kaempferol market segments, market trends, and opportunities, and any further data you may need to thrive in the kaempferol industry. This kaempferol market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The kaempferol market consists of sales of luteolin, apigenin, flavanol, polyphenol, and glycoside. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Kaempferol Market Characteristics3. Kaempferol Market Trends and Strategies4. Kaempferol Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market32. Global Kaempferol Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Kaempferol Market34. Recent Developments in the Kaempferol Market
5. Global Kaempferol Growth Analysis and Strategic Analysis Framework
6. Kaempferol Market Segmentation
7. Kaempferol Market Regional and Country Analysis
8. Asia-Pacific Kaempferol Market
9. China Kaempferol Market
10. India Kaempferol Market
11. Japan Kaempferol Market
12. Australia Kaempferol Market
13. Indonesia Kaempferol Market
14. South Korea Kaempferol Market
15. Western Europe Kaempferol Market
16. UK Kaempferol Market
17. Germany Kaempferol Market
18. France Kaempferol Market
19. Italy Kaempferol Market
20. Spain Kaempferol Market
21. Eastern Europe Kaempferol Market
22. Russia Kaempferol Market
23. North America Kaempferol Market
24. USA Kaempferol Market
25. Canada Kaempferol Market
26. South America Kaempferol Market
27. Brazil Kaempferol Market
28. Middle East Kaempferol Market
29. Africa Kaempferol Market
30. Kaempferol Market Competitive Landscape and Company Profiles
31. Kaempferol Market Other Major and Innovative Companies
35. Kaempferol Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Kaempferol Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on kaempferol market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for kaempferol? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The kaempferol market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Source: Tea; Fruits; Vegetables; Medicinal Plants2) By Purity: 10%, 20%, 50%,95%,98%
3) By Application: Food and Beverages; Cosmetics; Pharmaceuticals; Dietary Supplements; Other Applications
Subsegments:
1) By Tea: Green Tea; Black Tea; Herbal Tea2) By Fruits: Apples; Berries; Grapes; Citrus Fruits
3) By Vegetables: Kale; Spinach; Broccoli; Brussels Sprouts
4) By Medicinal Plants: Ginkgo Biloba; Eucalyptus; Ginger; Turmeric
Key Companies Mentioned: Fujifilm Wako Pure Chemical Corporation; Merk Millipore; LGC Group; Abcam plc; ChromaDex Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Fujifilm Wako Pure Chemical Corporation
- Merk Millipore
- LGC Group
- Abcam plc
- ChromaDex Corporation
- Cayman Chemical Company
- BioVision Inc.
- Clearsynth Labs Ltd.
- Enzo Life Sciences Inc.
- Santa Cruz Biotechnology Inc.
- AppliChem GmbH
- Conagen Inc.
- MedChemExpress LLC
- BioBioPha Co. Ltd.
- FoodChem International Corporation
- Oakwood Products Inc.
- Spectrum Chemical Mfg. Corp.
- Aktin Chemicals Inc.
- BOC Sciences
- AK Scientific Inc.
- Chemfaces Biochemical Co. Ltd
- INDOFINE Chemical Company Inc.
- Risun Bio-Tech Inc.
- Shaanxi NHK Technology
- TCI Chemicals (India) Pvt. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 4.35 Billion |
| Forecasted Market Value ( USD | $ 5.24 Billion |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
